·   Log in

Archive for March 1st, 2010

Indian Supreme Court refuses to stay Cipla’s Nexavar (sorafenib) on Bayer’s plea

Monday, March 1, 2010 21:01

Indian Supreme Court has rejected a plea from German drug giant Bayer AG seeking to block the marketing approval of a generic version of its patented kidney cancer drug Nexavar (sorafenib) by Cipla, reports said.

This was posted under category: Featured, Patents  |  Read Full Story  |  0 Comments
Tagged with: , ,

Ariad’s new drug AP24534 could offer hope for resistant leukemia

Monday, March 1, 2010 18:51

US FDA may fast-track the approval process of Ariad Pharmaceutical's investigational therapy  AP24534 to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: , ,

Avila’s protein silencing drug AVL-181 shows promise in hepatitis C infection

Monday, March 1, 2010 18:23

AVL-181, anti-viral drug to treat hepatitis C infection developed by Avila Therapeutics, Inc., will soon undergo clinical studies.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: ,

Serum Institute begins clinical studies on Lipoxen’s long-acting EPO drug ErepoXen in India

Monday, March 1, 2010 17:02

ErepoXen will be a once-a-month injection  as against other EPO drugs which are injected 1-3 times a week

This was posted under category: Biotech  |  Read Full Story  |  0 Comments

New treatment of baldness Platelet Rich Plasma therapy to go on clinical studies: Nanogen

Monday, March 1, 2010 16:57

A new line of treatment for baldness called Platelet Rich Plasma therapy will be evaluated in clinical trials to further ascertain its efficacy in stemming hair loss.

This was posted under category: Clinical Trials  |  Read Full Story  |  1 Comment
Tagged with: ,